AUSTRALIAN CANCER CARE NETWORK LAUNCHES TO LINK SERVICES TO POPULATION, CLINICIANS & RESEARCHERS
Aims to reduce health system disparities and tackle cancers with low survival rates
The landscape of cancer care in Australia is set to transform with the Australian Government launch in May 2024 of the Australian Comprehensive Cancer Network (ACCN) at the Innovations Showcase event, hosted by Cancer Australia in Sydney, Australia.
The ACCN is a nationally integrated system of cancer care, aimed at enhancing patient experiences and outcomes through coordinated and equitable access, by linking to comprehensive cancer services across Australia. Anchored by Comprehensive Cancer Centres (CCCs), the ACCN strives to deliver evidence-driven prevention, diagnosis, treatment, and support to all Australians affected by cancer.
Comprehensive Cancer Centres (CCCs) will serve as anchors in the ACCN, connecting various cancer control services nationwide. Through building partnerships and harnessing virtual connectivity, CCCs will collaborate with other cancer care centres, academic institutions, Aboriginal Community Controlled Health Services, regional hospitals and allied health services, among others.
While Australia has some of the world’s highest cancer survival rates, not all people experience equal outcomes. There are significant disparities in cancer outcomes for some populations, particularly affecting those in rural and remote regions, as well as Aboriginal and Torres Strait Islander communities.
The ACCN aims to address these disparities, emphasising coordinated and equitable access to comprehensive cancer services irrespective of where a person lives, and marking a significant milestone in the advancement of cancer care in Australia.
Australian Health Journal spoke with Professor Dorothy Keefe CEO, Cancer Australia on the ACCN launch and the network being a major milestone in the Australian Cancer Plan, which was launched at the end of 2023.
Participation in the ACCN is voluntary, with services committing to a set of standards focusing on comprehensive cancer care, equitable access, research excellence, data collection, workforce development, and network connectivity. Importantly, the ACCN will complement existing networks and alliances within the cancer care landscape, fostering collaboration and maximising resources.
All services and professionals involved in cancer care are encouraged to join the ACCN and contribute to this transformative initiative.
“As part of the implementation of the Australian Cancer Plan launched in November, the ACCN represents an essential stage towards achieving our goals of improving cancer outcomes and experiences for all Australians.”, says Professor Keefe.
She points out, “To achieve world class cancer outcomes for all Australians and realise the ambition of the Australian Cancer Plan, we need collective action from all sectors of health care to address issues that contribute to variation in cancer outcomes and experience.”
-
HIGHLIGHTS The power of social determinants of health, panel discussion
Clinicians and consumers know only too well that life circumstances such as poor housing, income and food insecurity can have a negative impact on health outcomes. Conversely, participation in community activities, social connection and access to nature parks and leisure facilities can help maintain health and wellbeing.
More recent phenomena in public health have also focused us on the health and social care connection. Stress factors such as the sudden loss of employment and social interaction, moving to remote work or schooling, and the impacts of sudden, localised COVID-19 ‘lockdowns’ to prevent further outbreaks were triggers of increased psychological distress.
And loneliness is being described as our latest epidemic with chronic loneliness inked to a myriad of health problems and earlier death. A recent report found one in four Australians say they feel persistently lonely, and that loneliness costs $2.7 bn a year in health costs alone.
-
Thyroid health into pregnancy
‘Without an adequate amount of thyroid hormone mothers can be exposed to hypertensive disorders of pregnancy, including gestational hypertension and preeclampsia or eclampsia, which affect around 10% of pregnant women and are the leading causes of maternal and neonatal mortality worldwide. Mothers who suffer from hypertensive disorders during pregnancy are at increased risk of long-term cardiovascular consequences and hypertensive disorders in subsequent pregnancies. Evidence also indicates a risk of reduced cognitive ability to their offspring.
‘Knowing if you are genetically predisposed to Hashimoto’s or Graves’ Diseases, which are both thyroid autoimmune disorders is important to be aware of, to ensure all appropriate tests are ordered. Autoimmune disorders may predispose mothers to a thyroid problem during pregnancy’, says Professor Creswell Eastman, who also serves as the ATF’s Principal Medical Advisor.
-
Taiwanese health and research delegation visit Paratus clinical trial site in Canberra
In late August 2025, a Taiwanese delegation comprising government officials from the Taiwanese FDA, various governmental groups, and physicians and researchers from across Taiwan, visited Paratus Clinical’s trial site in Canberra. Their objective was to explore both the differences and similarities between the clinical research ecosystems of Taiwan and Australia.
